Disclosures for "Impact of Real-World, Case-Driven CME Learning on Diagnostic and Therapeutic Practice in Rett Syndrome"
-
Ms. Gupta has nothing to disclose.
-
Carole Drexel has nothing to disclose.
-
Dr. Hasson has nothing to disclose.
-
Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.